Search

everythinglearnresearchcommunity

for

Search:↓

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Herbal remedies can cause adverse effects and need more safety research.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

A young tapir with a rare skin condition improved after treatment with wound cleaning, cream, and oral medication.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.